Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

BIOGEN INC. Director's Dealing 2024

Sep 5, 2024

30291_dirs_2024-09-05_c3b548fa-0d72-4ce3-bd70-53f0128a8f2b.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: BIOGEN INC. (BIIB)
CIK: 0000875045
Period of Report: 2024-08-30

Reporting Person: Singhal Priya (Head of Development)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2024-08-30 Common Stock M 1668 Acquired 6554.4761 Direct
2024-08-30 Common Stock F 807 $204.76 Disposed 5747.4761 Direct
2024-09-03 Common Stock S 431 $204.22 Disposed 5316.4761 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2024-08-30 Restricted Stock Unit $0 M 1668 Disposed 2025-09-01 Common Stock (1668) Direct

Footnotes

F1: This award was granted to the reporting person on September 1,
2022 and will vest in three equal installments on each anniversary of the grant date.